Torricelli Andre Augusto Miranda, Parede Taís Renata Ribeiro, Netto Marcelo Vieira, Crestana Francisco Penteado, Bechara Samir Jacob
Department of Ophthalmology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Arq Bras Oftalmol. 2016 Apr;79(2):88-91. doi: 10.5935/0004-2749.20160027.
To evaluate ocular straylight before and after photorefractive keratectomy (PRK) for low myopia with and without topical mitomycin (MMC) treatment.
Patients who underwent PRK for low myopia were enrolled into the study. PRK without MMC was performed in 21 eyes (12 patients), whereas PRK with topical 0.02% MMC was performed in 25 eyes (14 patients). Both groups were treated using the NIDEK EC5000 excimer laser. Measurements were performed using the C-Quant straylight meter preoperatively and at two and four months postoperatively.
The mean patient age was 30 ± 4 years, and the mean spherical equivalent refractive error was -2.2 ± 0.75 D. The mean preoperative intraocular straylight values were 1.07 ± 0.10 in the PRK without MMC group and 1.07 ± 0.11 log(s) in the PRK with topical MMC group. At two months after surgery, there was a decrease in mean intraocular straylight values in both groups. However, a significant difference was only reached in the PRK with MMC group [0.98 ± 0.09 log(s), p=0.002] compared with preoperative values, which was likely due to a greater scatter of measurements in the PRK without MMC group [1.03 ± 0.13 log(s), p=0.082]. At four months postoperatively, ocular straylight values were not significantly different compared with those at baseline in either the PRK without MMC group [1.02 ± 0.14 log(s), p=0.26] or in the PRK with topical MMC group [1.02 ± 0.11 log(s), p=0.13].
PRK for low myopia decreases ocular straylight, and MMC application further reduces straylight in the early postoperative period. However, ocular straylight values do not significantly differ at four months after surgery compared with those at baseline.
评估低度数近视患者在接受准分子激光原位角膜磨镶术(PRK)治疗前后,以及使用和不使用局部丝裂霉素(MMC)治疗时的眼内杂散光情况。
纳入接受PRK治疗的低度数近视患者。21只眼(12例患者)接受了不使用MMC的PRK治疗,而25只眼(14例患者)接受了局部使用0.02%MMC的PRK治疗。两组均使用NIDEK EC5000准分子激光进行治疗。术前以及术后2个月和4个月使用C-Quant杂散光仪进行测量。
患者平均年龄为30±4岁,平均等效球镜屈光不正为-2.2±0.75D。不使用MMC的PRK组术前平均眼内杂散光值为1.07±0.10,局部使用MMC的PRK组为1.07±0.11log(s)。术后2个月,两组的平均眼内杂散光值均有所下降。然而,与术前值相比,仅局部使用MMC的PRK组达到了显著差异[0.98±0.09log(s),p=0.002],这可能是由于不使用MMC的PRK组测量值的离散度更大[1.03±0.13log(s),p=0.082]。术后4个月,不使用MMC的PRK组[1.02±0.14log(s),p=0.26]或局部使用MMC的PRK组[1.02±0.11log(s),p=0.13]的眼内杂散光值与基线相比均无显著差异。
低度数近视的PRK治疗可降低眼内杂散光,使用MMC可在术后早期进一步降低杂散光。然而,术后4个月时眼内杂散光值与基线相比无显著差异。